English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Diabetic nephropathy remains a major cause of morbidity and mortality for persons with either T1DM or T2DM. Presently, diabetes is the leading single cause of ESRD. Globally, most patients with diabetes are in developing countries that do not have the resources or health infrastructure to provide universal renal replacement therapy. The ADA recommends screening for diabetic nephropathy with estimated glomerular filtration rate (eGFR) at least once a year. Normal GFR is 80130mm/min/1.73m

eGFR using CKD- EPI, MDRD and COCKCROFT - GAULT and glycaemic control among type 2 diabetics in an out-patient clinic in Nigeria